FasterCures creates unbiased analytical assessments of some of R&D's thorniest issues – from intellectual property to data sharing to alternative financing models – providing a roadmap for action.

Featured Publication

Rx for Innovation report cover

Rx for Innovation: Recommendations for the New Administration

Published: November 2016

FasterCures wants President Donald Trump to be ready to address biomedical innovation on day one. Biomedical innovation is vital to America's health and economic well-being. However, these benefits, and U.S. leadership in the life sciences, did not happen by accident and are not guaranteed to continue indefinitely. FasterCures staff interviewed more than 150 thought leaders across eight sectors. We combined insights from the interviews, discussions from a working session in Washington of health policy leaders and feedback received via our Web site to identify ideas for how to propel biomedical innovation forward. The Rx for Innovation report, prepared and authored by FasterCures policy team, presents our recommendations for how the administration can translate the ideas we heard into meaningful action.

Thought Leadership

Patient-Centered Research

Collaboration & Innovation

Translational Research

Venture Philanthropy

Archived Reports